{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:34Z","timestamp":1792602994302,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008482","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008482","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T18:02:50Z","timestamp":1597082570000},"page":"e0008482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous Leishmania major\u00a0infection"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-4694","authenticated-orcid":true,"given":"Alex G.","family":"Peniche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Yaneth","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Melby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno L.","family":"Travi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"issue":"5","key":"pntd.0008482.ref001","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"pntd.0008482.ref002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"The Lancet infectious diseases"},{"issue":"4","key":"pntd.0008482.ref003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"JD Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"pntd.0008482.ref004","first-page":"465","article-title":"Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies","volume":"87","author":"NC Hepburn","year":"1994","journal-title":"QJM"},{"issue":"4","key":"pntd.0008482.ref005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0035-9203(94)90432-4","article-title":"Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis","volume":"88","author":"NC Hepburn","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"pntd.0008482.ref006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"LF Oliveira","year":"2011","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0008482.ref007","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/S0036-46652004000200010","article-title":"Mapping of a Leishmania major gene\/locus that confers pentamidine resistance by deletion and insertion of transposable element","volume":"46","author":"AC Coelho","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"pntd.0008482.ref008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.molbiopara.2006.08.013","article-title":"Intracellular location of the ABC transporter PRP1 related to pentamidine resistance in Leishmania major","volume":"150","author":"AC Coelho","year":"2006","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"pntd.0008482.ref009","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"AC Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008482.ref010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.intimp.2019.02.008","article-title":"Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways","volume":"69","author":"M Bamorovat","year":"2019","journal-title":"International immunopharmacology"},{"issue":"5","key":"pntd.0008482.ref011","doi-asserted-by":"crossref","first-page":"e0003820","DOI":"10.1371\/journal.pntd.0003820","article-title":"Ex vivo host and parasite response to anti-leishmanial drugs and immunomodulators","volume":"9","author":"L Gonzalez-Fajardo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008482.ref012","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/1471-2334-14-491","article-title":"A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments","volume":"14","author":"WL Dos-Santos","year":"2014","journal-title":"BMC infectious diseases"},{"issue":"21\u201322","key":"pntd.0008482.ref013","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"W Zheng","year":"2013","journal-title":"Drug Discov Today"},{"issue":"24","key":"pntd.0008482.ref014","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1016\/j.bmc.2008.10.042","article-title":"Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives","volume":"16","author":"R Weis","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"pntd.0008482.ref015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1475-2875-13-143","article-title":"Repositioning: the fast track to new anti-malarial medicines?","volume":"13","author":"J Lotharius","year":"2014","journal-title":"Malar J"},{"issue":"6","key":"pntd.0008482.ref016","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0035-9203(97)90526-5","article-title":"Comparative efficacy of chloroquine\/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in Nigerian children","volume":"91","author":"A Sowunmi","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"pntd.0008482.ref017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1590\/S0074-02762007005000038","article-title":"Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo","volume":"102","author":"A Sowunmi","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7","key":"pntd.0008482.ref018","doi-asserted-by":"crossref","first-page":"e0003932","DOI":"10.1371\/journal.pntd.0003932","article-title":"Histamine 1 Receptor Blockade Enhances Eosinophil-Mediated Clearance of Adult Filarial Worms","volume":"9","author":"EM Fox","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008482.ref019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2019.04.017","article-title":"Anti-leishmanial activity of H1-antihistamine drugs and cellular alterations in Leishmania (L.) infantum","volume":"195","author":"V de Melo Mendes","year":"2019","journal-title":"Acta Trop"},{"key":"pntd.0008482.ref020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actatropica.2014.05.017","article-title":"Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes","volume":"137","author":"EG Pinto","year":"2014","journal-title":"Acta Trop"},{"issue":"1","key":"pntd.0008482.ref021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.00887-13","article-title":"Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major","volume":"58","author":"AG Peniche","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0008482.ref022","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.135.1.564","article-title":"Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes","volume":"135","author":"DL Sacks","year":"1985","journal-title":"J Immunol"},{"issue":"4","key":"pntd.0008482.ref023","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tiv.2005.01.003","article-title":"Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake","volume":"19","author":"WG Schoonen","year":"2005","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"pntd.0008482.ref024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tiv.2008.11.012","article-title":"Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach","volume":"23","author":"HH Gerets","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"pntd.0008482.ref025","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/srep04659","article-title":"A simple, inexpensive method for preparing cell lysates suitable for downstream reverse transcription quantitative","volume":"4","author":"K Shatzkes","year":"2014","journal-title":"PCR. Scientific reports"},{"issue":"24","key":"pntd.0008482.ref026","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1093\/nar\/gng154","article-title":"A PCR primer bank for quantitative gene expression analysis","volume":"31","author":"X Wang","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"47","key":"pntd.0008482.ref027","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.3748\/wjg.v23.i47.8321","article-title":"Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model","volume":"23","author":"BR Chen","year":"2017","journal-title":"World journal of gastroenterology"},{"issue":"2","key":"pntd.0008482.ref028","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpddr.2016.03.002","article-title":"Corrigendum to 'Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cells' [Int. J. Parasitol. Drugs Drug Resist. 4 (2014) 14\u201319]","volume":"6","author":"E van den Bogaart","year":"2016","journal-title":"International journal for parasitology Drugs and drug resistance"},{"issue":"2","key":"pntd.0008482.ref029","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4269\/ajtmh.11-0812","article-title":"Drug discovery algorithm for cutaneous leishmaniasis","volume":"88","author":"M Grogl","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"pntd.0008482.ref030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"K Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"pntd.0008482.ref031","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/AAC.30.6.847","article-title":"Anti-leishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys","volume":"30","author":"JD Berman","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pntd.0008482.ref032","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin","volume":"85","author":"M Grogl","year":"1999","journal-title":"J Parasitol"},{"issue":"3","key":"pntd.0008482.ref033","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2125.2006.02689.x","article-title":"Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein","volume":"62","author":"M Shimizu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"pntd.0008482.ref034","doi-asserted-by":"crossref","first-page":"e0184777","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review","volume":"12","author":"NC Brito","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"pntd.0008482.ref035","doi-asserted-by":"crossref","first-page":"e0006653","DOI":"10.1371\/journal.pntd.0006653","article-title":"A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia","volume":"12","author":"L Lopez","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0008482.ref036","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"M Solomon","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"pntd.0008482.ref037","first-page":"77","article-title":"Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial","volume":"14","author":"JM Camarasa","year":"2001","journal-title":"Skin pharmacology and applied skin physiology"},{"key":"pntd.0008482.ref038","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actatropica.2014.05.017","article-title":"Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes","volume":"137","author":"EG Pinto","year":"2014","journal-title":"Acta Tropica"},{"issue":"5","key":"pntd.0008482.ref039","doi-asserted-by":"crossref","first-page":"e1533","DOI":"10.1371\/journal.pntd.0001533","article-title":"Disease severity in patients infected with Leishmania mexicana relates to IL-1beta","volume":"6","author":"EA Fernandez-Figueroa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008482.ref040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2019.05.005","article-title":"Inflammasomes and Leishmania: in good times or bad, in sickness or in health","volume":"52","author":"DS Zamboni","year":"2019","journal-title":"Current opinion in microbiology"},{"issue":"6","key":"pntd.0008482.ref041","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.159.6.2932","article-title":"Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation","volume":"159","author":"I Hide","year":"1997","journal-title":"J Immunol"},{"issue":"5","key":"pntd.0008482.ref042","first-page":"481","article-title":"Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells","volume":"12","author":"S Matsuo","year":"1998","journal-title":"In Vivo"},{"issue":"4","key":"pntd.0008482.ref043","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/all.12109","article-title":"FcepsilonRI stimulation promotes the differentiation of histamine receptor 1-expressing inflammatory macrophages","volume":"68","author":"N Novak","year":"2013","journal-title":"Allergy"},{"issue":"3","key":"pntd.0008482.ref044","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bcp.2015.09.011","article-title":"Histamine H(1)- and H(4)-receptor signaling cooperatively regulate MAPK activation","volume":"98","author":"S Beermann","year":"2015","journal-title":"Biochemical pharmacology"},{"issue":"7","key":"pntd.0008482.ref045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"DS Lima-Junior","year":"2013","journal-title":"Nature medicine"},{"issue":"3","key":"pntd.0008482.ref046","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.imbio.2016.11.004","article-title":"Changes in gene expression induced by histamine, fexofenadine and osthole: Expression of histamine H1 receptor, COX-2, NF-kappaB, CCR1, chemokine CCL5\/RANTES and interleukin-1beta in PBMC allergic and non-allergic patients","volume":"222","author":"NK Kordulewska","year":"2017","journal-title":"Immunobiology"},{"issue":"3","key":"pntd.0008482.ref047","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000096016","article-title":"New evidence of H1-receptor independent COX-2 inhibition by fexofenadine HCl in vitro","volume":"78","author":"UR Juergens","year":"2006","journal-title":"Pharmacology"},{"issue":"3","key":"pntd.0008482.ref048","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1590\/S1517-83822011000300018","article-title":"In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates","volume":"42","author":"MA El-Nakeeb","year":"2011","journal-title":"Braz J Microbiol"},{"issue":"3","key":"pntd.0008482.ref049","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1590\/S1517-83822011000300019","article-title":"Membrane permeability alteration of some bacterial clinical isolates by selected antihistaminics","volume":"42","author":"MA El-Nakeeb","year":"2011","journal-title":"Braz J Microbiol"},{"issue":"11","key":"pntd.0008482.ref050","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.2042-7158.1975.tb10221.x","article-title":"The interaction of antihistamines with lecithin monolayers","volume":"27","author":"D Attwood","year":"1975","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"pntd.0008482.ref051","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1076\/ocii.11.4.247.18261","article-title":"Interactions of olopatadine and selected antihistamines with model and natural membranes","volume":"11","author":"HL Brockman","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"pntd.0008482.ref052","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00034983.1989.11812354","article-title":"The effect of pentostam and cimetidine on the development of leishmaniasis (Leishmania mexicana amazonensis) and concomitant malaria (Plasmodium yoelii)","volume":"83","author":"RE Coleman","year":"1989","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"pntd.0008482.ref053","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0035-9203(88)90425-7","article-title":"Effect of cimetidine and 2'-deoxyguanosine on the development of Leishmania mexicana in Balb\/C mice","volume":"82","author":"RE Coleman","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008482","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T14:52:03Z","timestamp":1696517523000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008482"}},"subtitle":[],"editor":[{"given":"Sima","family":"Rafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008482","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008482","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}